Collegium Pharmaceutical Inc Working Capital to Net Assets Ratio
Collegium Pharmaceutical Inc working capital to net assets ratio. Collegium Pharmaceutical Inc (COLL) has a Working Capital to Net Assets ratio of 58.6% as of September 2025. Working capital of $160.94 Million (current assets of $613.87 Million minus current liabilities of $452.93 Million) is measured against net assets of $274.81 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Collegium Pharmaceutical Inc (2013–2024)
Working capital to net assets ratio of Collegium Pharmaceutical Inc from 2013 to 2024. This chart shows how Collegium Pharmaceutical Inc's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2013 to 2024. As of September 2025, the ratio stands at 58.6%, reflecting working capital of $160.94 Million against net assets of $274.81 Million USD. See how many days can Collegium Pharmaceutical Inc fund operations to measure how many days the company can operate on defensive assets alone.
Collegium Pharmaceutical Inc Working Capital to Net Assets Ratio by Year (2013–2024)
Collegium Pharmaceutical Inc working capital to net assets ratio by year from 2013 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Collegium Pharmaceutical Inc from 2013 to 2024, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see total assets of Collegium Pharmaceutical Inc.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | -11.9% | $-27.25 Million | $228.84 Million | $482.26 Million | $509.51 Million | ▼ -52.7 pp |
| 2023 | 40.8% | $79.69 Million | $195.43 Million | $537.60 Million | $457.92 Million | ▲ +47.8 pp |
| 2022 | -7.1% | $-13.74 Million | $194.84 Million | $419.99 Million | $433.73 Million | ▼ -24.8 pp |
| 2021 | 17.7% | $35.98 Million | $202.93 Million | $315.54 Million | $279.57 Million | ▼ -2.9 pp |
| 2020 | 20.7% | $38.44 Million | $186.03 Million | $277.89 Million | $239.45 Million | ▼ -41.0 pp |
| 2019 | 61.7% | $53.95 Million | $87.43 Million | $255.72 Million | $201.76 Million | ▲ +7.1 pp |
| 2018 | 54.6% | $50.03 Million | $91.58 Million | $237.51 Million | $187.48 Million | ▼ -43.4 pp |
| 2017 | 98.0% | $102.00 Million | $104.08 Million | $133.48 Million | $31.49 Million | ▼ -2.5 pp |
| 2016 | 100.5% | $135.65 Million | $134.91 Million | $158.57 Million | $22.93 Million | ▼ -6.6 pp |
| 2015 | 107.1% | $91.12 Million | $85.07 Million | $96.88 Million | $5.76 Million | ▲ +58.7 pp |
| 2014 | 48.4% | $-5.92 Million | $-12.24 Million | $4.50 Million | $10.42 Million | ▼ -52.7 pp |
| 2013 | 101.1% | $5.64 Million | $5.58 Million | $8.26 Million | $2.62 Million | — |